• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 18.60
  • VXN 23.66
  • VXO 18.16
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





NO
Refresh      
LCI (Lannett Co Inc)
Last Trade 7.44 Dividend/Share 0 PE Ratio 2.4
Date 12:13:36 PM Dividend Yield 0.000 Return on Assets -18.94
Change -0.34 ExDividend Date 0 Return on Capital null
Bid 7.44 Latest EPS 0.75 Price/Sale 0.607
Ask 7.48 LatestEPS Date 2018-06-30 Price to Book 0.97
Volume 25492 EPS ttm 3.100 Institutional % 113.3
Avg Volume 1.63M Shares Outstanding 39.27M Insider % 32.7
Open 7.79 Float 26.83M Short Ratio 11.010
Prev Close 7.78 Return On Equity -61.26 5 Year Change % -0.785
High 7.886 Consensus EPS 0.64 2 Year Change % -0.602
Low 7.12 No. of Estimate 3.000 1 Year Change % -0.681
52 Week High 25.025 EPS Surprise $ null YTD Change % 0.454
52 Week Low 3.33 EPS Surprise Percent 0 6 Month Change % -0.380
52 Week Change -68.727 EBITDA 0M 3 Month Change % 0.940
50 Day MA 5.3926 Revenue 0M 1 Month Change % 0.604
200 Day MA Gross Profit 0M 5 Day Change % 0.091
Market Cap 305.51M Cash 0M 30 Day Change % 0.319
Beta 2.265306 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 14969683
Short Date 2018-12-31 Revenue Per Employee 0 Short Ratio 11.010
Data courtesy of IEX
Company Profile

Lannett Company, Inc. develops, manufactures, markets, and distributes generic versions of pharmaceutical products in the United States. The company manufactures and/or sells various prescription products. Its product portfolio includes acetazolamide, baclofen, and bethanechol chloride tablets; amantadine gel capsules; butalbital, aspirin, and caffeine with codeine phosphate, danazol, and clindamycin HCl capsules; cocaine topical solution; and dicyclomine tablets and capsules. The company?s products also comprise digoxin, dipyridamole, doxycycline, doxycycline hyclate, esterified estrogen and methyltestoterone, hydrochlorothiazide, hydromorphone HCl, and levothyroxine sodium tablets; morphine sulfate oral solutions; and OB-natal one gel capsules. In addition, its products consist of pilocarpine HCl, primidone, probenecid, terbutaline sulfate, and unithroid tablets; oxycodone HCl oral solution; rifampin and ursodiol capsules; and phentermine HCl tablets and capsules. Lannett Company markets its products under the brand names of Diamox, Symmetrel, Lioresal, Urecholine, Fiorinal, Cleocin, Danocrine, Bentyl, Lanoxin, Persantine, Adoxa, Periostat, Estratest, Hydrodiuril, Dilaudid, Levoxyl/ Synthroid, Roxanol, PrimaCare ONE, Roxicodone, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Actigall, and Fiorinal w/ Codeine #3. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.